Click Therapeutics

Click Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.clicktherapeutics.com

Last Round

Series D

Apr 9, 2026

Est. Valuation

$312.53M

Total Funding Raised

$283.23M

Company Overview

Click Therapeutics is a digital health company that offers a prescription platform for software-based medical treatments aimed at providing safe and effective digital therapies for patients with brain disorders and neuro-psychiatric conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Medical AI, Clinical Trials, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

digital therapeuticsDTxprescription digital therapeuticsPDTFDA cleared softwaredigital medicinesoftware-as-treatmentprescription appsoftware as a medical deviceSaMDpharma partnershipsneurobehavioral therapymajor depressive disordermigraine treatmentschizophrenia treatmentsmoking cessation apppayer reimbursement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Click Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Click Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DApr 9, 2026
Series CMar 19, 2025
Growth EquityApr 3, 2024
DebtNov 6, 2023
DebtApr 15, 2022
Series B
Oct 22, 2021

Click Therapeutics Investors

Notable investors and investment history

InvestorRounds
Boehringer IngelheimGrowth Equity, Series D
Accelmed Partners IISeries B
HIG BioHealth PartnersSeries B
Health Catalyst Capital ManagementSeries B
Dassault SystèmesSeries C
Supernode VenturesSeed, Series A
Sanofi VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    25 employees laid off, representing over 25% of the team.

  • Apr 9, 2026

    $50M Series D round completed.

Click Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Click Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Click Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range143
Year Founded2012
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.